Skip to Main Navigation

RMI COVID-19 Emergency Response Project

Abstract*

The Program Development Objective of the COVID-19 Response Project in the Republic of the Marshall Islands (RMI) is to prevent, detect and respond to the threat posed by COVID-19 (Coronavirus) and strengthen national systems for public health preparedness. This project consists of two components. Component one is the Emergency COVID-19 Response. This component will provide immediate support to the RMI to prevent COVID-19 (Coronavirus) from arriving...

* The project abstract is drawn from the PAD, SAR or PGD and may not accurately reflect the project's current nature

Show More

Development Objective

To prevent and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness in the Republic of the Marshall Islands.

Key Details

Project Details

  • P173887

  • Closed

  • Nang Kham

  • The Republic of the Marshall Islands

  • Marshall Islands

  • April 10, 2020

  • (as of board presentation)

    April 16, 2020

  • April 29, 2020

  • US$ 2.50 million

  • Ministry of Health and Human Services

  • East Asia and Pacific

  • 2020

  • US$ 2.50 million

  • N/A

  • May 22, 2024

  • October 31, 2023

  • TBD

  • BANK APPROVED

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
IDA Grant 2.50

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment N/A
IDA Commitment 2.50
IBRD + IDA Commitment 2.50
Lending Instrument
Grant Amount N/A
Total Project Cost** 2.50

Summary Status of World Bank Financing (US$ Millions) as of February 28, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of February 28, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)
Jun 25, 2020 IDA-D6240 Loan Disb 1,500,000.00
May 5, 2020 IDA-D6240 Loan Disb 100,000.00
Nov 10, 2020 IDA-D6240 Loan Disb 6,834.41
Aug 12, 2021 IDA-D6240 Loan Disb 16,008.84
Nov 30, 2020 IDA-D6240 Loan Disb 189,755.00
Feb 29, 2024 IDA-D6240 Loan Cancel 96,173.65
Jun 12, 2023 IDA-D6240 Loan Disb 216,683.77
Nov 4, 2022 IDA-D6240 Loan Disb 5,845.03
Apr 12, 2023 IDA-D6240 Loan Disb 408,536.94
Apr 16, 2020 IDA-D6240 Loan Commitment 2,500,000.00
Feb 28, 2024 IDA-D6240 Loan Disb 19,207.32
Dec 8, 2020 IDA-D6240 Loan Disb 45,290.01

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Overall Implementation Progress (IP) Satisfactory 2024-02-18
Progress towards achievement of PDO Satisfactory 2024-02-18
Financial Management Moderately Satisfactory 2024-02-18
Monitoring and Evaluation Satisfactory 2024-02-18
Procurement Satisfactory 2024-02-18
Project Management Moderately Satisfactory 2024-02-18

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • Number of community non-pharmaceutical COVID-19 containment strategies deployedValue2.0021.008.00
    DateApril 1, 2020October 31, 2023October 31, 2023
    Comment
  • Total number of cases of COVID-19 reported and investigated per MOHHS protocolValue2.0028.0020.00
    DateApril 1, 2020October 31, 2023October 31, 2023
    Comment
  • Number of staff trained in infection prevention and control per MOHHS protocolValue0.00726.00250.00
    DateApril 1, 2020October 31, 2023October 31, 2023
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • First COVID-19 case reported to WHO and CDC within 24 hours of confirmation per IHR requirementsValueNoYesYes
    DateApril 1, 2020October 31, 2023October 31, 2023
    Comment
  • At least one multisectoral simulation exercise conducted with results incorporated into national COVID-19 preparedness and responseplansValueNoYesYes
    DateApril 1, 2020October 31, 2023October 31, 2023
    Comment
  • Number of designated laboratories with COVID-19 diagnostic capacityValue0.003.002.00
    DateApril 1, 2020October 31, 2023October 31, 2023
    Comment
  • Number of policies, regulations, guidelines, or other relevant government strategic documents incorporating a multisectoral approach for health emergencies developed or revised, and adoptedValue0.0010.004.00
    DateApril 1, 2020October 31, 2023October 31, 2023
    Comment
  • Percent of grievances handled according to proscribed timelinesValue0.000.0085.00
    DateApril 24, 2020June 27, 2023October 31, 2023
    Comment